Syndax Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Great. Thank you. Good afternoon, everyone. My name is Pete Lawson. I'm one of the biotech analysts at Barclays, and welcome to Barclays Global Healthcare Conference. I just wanted to thank everyone for taking time out that day. And we've got management team from Syndax. If you've got questions, institutional investors can e-mail me at [email protected] or ping me on Bloomberg and my pleasure to introduce the management team from Syndax. So we've got the full suite of management essentially. Briggs, Daphne, Michael, and Anjali, and it's my pleasure to speak to you guys today, and thanks for joining. And I guess, just to kick things off.
Questions & Answers
I guess the question I've been asking today has just been around like the company's differentiation in the oncology space is plenty of oncology companies, what do you kind of view as the differentiation? What are your core competencies in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |